在急性息治疗病房治疗的晚期癌症患者的食欲丧失
Elisabeth Hagen Helgesen1, Ragnhild Ulevåg1, Tora Skeidsvoll Solheim1,2
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, 7030 Trondheim, Norway.
Current oncology (Toronto, Ont.)
|October 25, 2024
概括
食欲丧失影响了许多晚期癌症患者,但干预措施可以帮助. 这项研究发现,改善食欲往往与减少疲劳相吻合,尤其对那些独自生活的人来说.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 在瘤学瘤学.
- 症状管理 症状管理
背景情况:
- 食欲丧失是晚期癌症患者常见的,令人虚弱的症状,严重影响了他们的生活质量.
- 对于与食欲丧失相关的因素以及对这一群体的干预措施的有效性,人们的了解有限.
研究的目的:
- 探索患者特征和治疗性干预措施,以或没有食欲丧失的晚期癌症患者.
- 在急性息护理环境中识别与食欲丧失和食欲改善相关的因素.
主要方法:
- 从急性息护理单位回顾分析患者数据.
- 包括患者特征和患者报告的结果指标 (PROMs),使用11点数值评分表 (NRS).
- 描述性统计,独立样本T测试和千平方测试用于数据分析.
主要成果:
- 在167名晚期癌症患者中,62%的患者在入院时经历了中度至严重的食欲丧失.
- 食欲丧失与胃肠道癌症,独自生活,表现不佳状态和停止抗癌治疗有关.
- 失去食欲的患者报告恶心,抑郁,疲劳,呼吸障碍和焦虑增加.
- 63%的食欲丧失患者在住院期间表现出改善,NRS平均下降3.4.
- 食欲的改善与独自生活有关,并且经常与减轻疲劳相吻合.
结论:
- 在晚期癌症患者中,食欲丧失很普遍,并且与特定的临床因素和心理痛苦有关.
- 息治疗期间的干预可以改善食欲,从而改善症状管理和生活质量.
- 进一步研究针对晚期癌症食欲丧失的有针对性的干预措施是有必要的,考虑到社会支持和疲劳等因素.
相关概念视频
01:27Nursing Ethical Principles II
924
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
924
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
149
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
149
01:25Continuing Care
1.4K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.4K
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
83
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
83
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
175
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
175